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Infections of virulent and avirulent 
viruses differentially influenced the 
expression of dicer-1, ago-1, and 
microRNAs in Bombus terrestris
Jinzhi Niu1,2, Ivan Meeus2, Dieter IM De Coninck3, Dieter Deforce3, Kayvan Etebari4, 
Sassan Asgari4 & Guy Smagghe1,2
The microRNA (miRNA) pathway is well established to be involved in host-pathogen interactions. 
As key insect pollinators, bees are suffering from widely spreading viruses, especially honeybees and 
bumblebees. In order to better understand bee-virus interaction, we comparatively analyzed the 
involvement of the bumblebee miRNA pathway upon infection by two different viruses. In our setup, 
an avirulent infection is induced by slow bee paralysis virus (SBPV) and a virulent infection is induced by 
Israeli acute paralysis virus (IAPV). Our results showed the increased expressions of dicer-1 and ago-1 
upon SBPV infection. There were 17 and 12 bumblebee miRNAs differentially expressed upon SBPV and 
IAPV infections, respectively. These results may indicate the involvement of the host miRNA pathway in 
bumblebee-virus interaction. However, silencing of dicer-1 did not influence the genome copy number 
of SBPV. Target prediction for these differentially expressed miRNAs showed their possible involvement 
in targeting viral genomic RNA and in the regulation of networks in bumblebee. Our study opens a new 
insight into bee-virus interaction meditated by host miRNAs.
RNA interference (RNAi) is a conserved mechanism for posttranscriptional gene silencing to regulate gene 
expression and defense against viral infection in insects. Currently, three sub-pathways are recognized under 
the RNAi pathway based on the produced small RNAs, including: small interfering RNA (siRNAs), microRNAs 
(miRNA), and Piwi-interacting RNAs (piRNAs) pathways. In bees, two aspects of the siRNA-pathway-mediated 
antiviral response has been considered: virus derived siRNAs and utilization of this pathway to control virus 
through virus-specific dsRNA1. Our previous study in the bumblebee Bombus terrestris showed that Israeli acute 
paralysis virus (IAPV) replicated very fast and acted as a very virulent virus whereas slow bee paralysis virus 
(SBPV) also replicated fast but induced no mortality after injection; furthermore, both IAPV and SBPV infections 
could induce the expression of dicer-2, while IAPV, but not SBPV, infection triggered the production of predom-
inantly 22 nt-long virus-derived siRNAs2.
As another important sub-pathway of RNAi in insects, the miRNA pathway has been documented to be 
involved in different aspects of development, such as formation of germ cells, wing and muscle, neurogenesis, 
apoptosis, and phenotypic plasticity3, while this pathway is also well established to be involved in host-pathogen 
interactions3,4. The canonical biogenesis of miRNAs initiates in the nucleus where monocistronic, bicistronic 
or polycistronic transcripts are produced. These contain stem-loop structures known as the primary miRNA 
(pri-miRNA). The pri-miRNA is cleaved by Drosha and Pasha to liberate the precursor miRNA (pre-miRNA). 
After exportation to the cytoplasm, the hairpin head of the pre-miRNA stem-loop is cut by Dicer-1 to yield a 
miRNA duplex. The miRNA duplex is then loaded into RNA induced silencing complex (RISC), which typi-
cally includes Argonaut 1 (Ago-1), resulting in the degradation of one of the strands. Then, the mature miRNA 
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binds to the target mRNA and leads to mRNA degradation or translational repression5. Besides, there are also 
non-canonical pathways of miRNA biogenesis, which are Drosha-independent but can be Dicer-dependent or 
Dicer-independent6. The production and regulatory effects of miRNAs on insect-virus interactions could be com-
plex. The first layer of complexity relates to the origin of miRNAs, which could be derived from the host or the 
virus. The second layer of complexity arises from the two-way interplay, meaning host-encoded miRNAs can 
target genes from both the host and the virus, and vice versa for virus encoded miRNAs7.
Differential expression of miRNAs has been associated with honeybee development and social behaviors8–11. 
Recently, with the genome sequencing of two bumblebee species, Bombus terrestris and B. impatiens, two datasets 
of miRNAs have been annotated for both species12. However, the regulatory effect of the miRNA pathway on 
bee-virus interaction is still unknown. Thus, in the current report, we comparatively analyzed the involvement of 
bumblebee miRNAs upon infections of an avirulent virus SBPV and a virulent virus IAPV. First, we analyzed the 
expression of the core genes (dicer-1 and ago-1) of the miRNA pathway upon virus infection. Secondly, through 
small RNA sequencing, we analyzed the miRNA profiles following viral infections. To have a further insight into 
miRNA-mRNA interaction, we predicted the possible targets for these miRNAs. Finally, we silenced dicer-1 to 
analyze the outcome of SBPV infection. Our study showed different features of the miRNA pathway response 
between the infection by the avirulent and the virulent virus, which may be associated with the virulence of the 
bee viral infections. In addition, these initial data could be the starting point to understand the function of miR-
NAs in cell regulatory systems of bee-virus interactions.
Results and Discussion
Significant effects of SBPV and IAPV infections on the expressions of dicer-1 and ago-1. Aside 
from some non-canonical pathways of miRNA biogenesis, both Dicer-1 and Ago-1 are the core components of 
miRNA biogenesis and determine the pathway’s activity on gene regulation6. Here, we measured the expression 
of B. terrestris dicer-1 and ago-1 upon viral infections. In Niu et al.2, we showed that SBPV and IAPV replicated 
fast, but the two viruses differed largely in causing mortality in bees: SBPV as an avirulent virus and IAPV as 
an extremely virulent virus2. In the current study, we have separated PBS controls for the two viruses, thus we 
used independent t-test to separate means of the expressions of dicer-1 and ago-1. For IAPV (four time points) 
and SBPV (six time points) the Bonferroni corrected p values were 0.0125 and 0.0083, respectively. Our results 
showed that only a noticeable increase of both dicer-1 and ago-1 was observed upon IAPV at 3 days post infec-
tion (dpi) (Fig. 1), while both dicer-1 (t-test: t = 5.861, df = 8, p < 0.001) and ago-1 (t-test: t = 5.370, df = 4.578, 
p = 0.004) were significantly upregulated at 2 dpi of SBPV (Fig. 1 and Table S1).
Small RNA sequencing reveals differentially expressed miRNAs upon SBPV and IAPV infec-
tions. Above we presented indications that the expression of core components of the miRNA pathway could 
be altered upon viral infections in B. terrestris, especially after SBPV infection, which implied the potential 
involvement of the miRNA pathway in host-virus interaction. To explore this possibility further, we used small 
RNA sequencing to find out which miRNAs could be influenced. Currently, there are 217 miRNAs described 
for the honeybee Apis mellifera in miRBase, while in the two bumblebee species, B. terrestris and B. impatiens, 
130 and 115 miRNAs have been identified, respectively12. Our results revealed that 17 and 12 host miRNAs 
were differentially expressed upon infection with SBPV and IAPV, respectively (Table 1, Table S2 and S3). From 
the 17 miRNAs differentially expressed in bumblebees infected with SBPV, 10 miRNAs were upregulated and 
Figure 1. Fold changes of two core gene expressions in the miRNA pathway upon IAPV and SBPV 
infection. (A) Fold change of dicer-1 expression upon viral infections; (B) Fold change of ago-1 expression upon 
viral infections. The fold changes of gene expression were equal to the ratio of the relative expression of each 
gene in virus infected samples over the relative expression of this gene in control samples (PBS injected bees) 
(n = 4~5). The relative expression of each gene was calculated based on internal reference gene PPIA. The error 
bar represented the standard error of mean. The level of significance was calculated by t-test, and p < 0.0125 for 
the group of IAPV and p < 0.0083 for the group of SBPV was labeled with asterisks (*), respectively.
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7 were downregulated. In bumblebees infected with IAPV, 12 miRNAs were differentially expressed, which 
included 7 upregulated and 5 downregulated miRNAs. Among all these differentially expressed miRNAs, 3 miR-
NAs (bte-miR-277, bte-bantam, and bte-miR-263a) were upregulated and 3 (bte-miR-3759, bte-miR-11, and 
bte-miR-24) were downregulated in both viral infections.
Table 1 summarizes the potential functions of the differentially abundant miRNAs based on the function of 
homologous miRNAs demonstrated in others insects. Two reappearing functions (apoptosis and energy homeo-
stasis), known to be regulated by miRNAs, struck our attention as they have also been described to be important 
factors in virus-host interactions.
Apoptosis. Homologous miRNAs of bte-miR-263a, bte-bantam, and bte-miR-11, three commonly differen-
tially regulated miRNAs during SBPV and IAPV infections, have been shown to be involved in apoptosis13–15. In 
miRNA name





Homologous miRNA functions (target) 
in insects Prediction of homologous targets or related targets in Bombus terrestris
bte-miR-13b 2.26 Juvenile hormone signaling pathway18 insulin-like growth factor 2 mRNA-binding protein 1-like (LOC100647990); ecdysone-induced protein 75B, isoforms C/D-like, (LOC100644185)
bte-miR-927a 1.75
bte-miR-277 1.60 1.45 Branched-chain amino acid catabolism
33 
Neurodegeneration34
insulin receptor substrate 1-like (LOC100644779); insulin-degrading enzyme-like 
(LOC100644699)
bte-miR-263b 1.54 Apoptosis14
apoptosis-inducing factor 1, mitochondrial-like (LOC100651200); cell division cycle 
and apoptosis regulator protein 1-like (LOC100651179); apoptosis 2 inhibitor-like 
(LOC100647685); apoptosis regulator R1-like (LOC100649633); PRKC apoptosis WT1 
regulator protein-like, transcript variant 1 (LOC100649375)
bte-bantam 1.49 1.28 Apoptosis
13 Stem cell regulation35; Cell 
proliferation36 Tumor suppressor37
apoptosis 2 inhibitor-like (LOC100650673); SWI/SNF-related matrix-associated 
actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1-like 
(LOC100645044); disks large 1 tumor suppressor protein-like (LOC100643982); fat-like 
cadherin-related tumor suppressor homolog (LOC100650960); cadherin-related tumor 
suppressor-like (LOC100651028)
bte-miR-9a 1.36 Wing development
38 Transcription factor of 
senseless39,40;
neurogenic locus Notch protein-like (LOC100645932); strawberry notch-like 
(LOC100649094)
bte-miR-31a 1.32
bte-miR-263a 1.26 1.42 Apoptosis14
apoptosis-inducing factor 1, mitochondrial-like (LOC100651200); cell division cycle 
and apoptosis regulator protein 1-like (LOC100651179); apoptosis-inducing factor 
3-like, transcript variant 1 (LOC100649657)
bte-miR-10 1.26
bte-miR-750 1.22
bte-miR-305 1.30 Intestinal stem cells20
insulin-like growth factor-binding protein complex acid labile subunit-like 
(LOC100651887); insulin-degrading enzyme-like (LOC100644699); insulin-like peptide 
receptor-like (LOC100645413); insulin-like receptor-like (LOC100650952); insulin-like 
growth factor-binding protein complex acid labile subunit-like (LOC100643961)
bte-miR-13a 1.30 juvenile hormone signaling pathway18
insulin-like growth factor-binding protein complex acid labile subunit-like 
(LOC100647673); insulin-like receptor-like (LOC100651348); ecdysone-induced 
protein 75B, isoforms C/D-like (LOC100644185)
bte-miR-278 1.28 Energy homeostasis16 P450s 17
insulin-like peptide receptor-like (LOC100645413); insulin gene enhancer protein 
ISL-1-like (LOC100644486); cytochrome P450 18a1-like (LOC100642897); cytochrome 
P450 49a1-like (LOC100646342); cytochrome P450 4C1-like (LOC100651255); 
cytochrome P450 4g15-like (LOC100652170); cytochrome P450 6a13-like 
(LOC100646677); cytochrome P450 6a2-like (LOC100646434), (LOC100647785), 
(LOC100651291), (LOC100647041); cytochrome P450 6k1-like (LOC100642816), 
(LOC100642936), (LOC100643678), (LOC100647803), (LOC100648391), 
(LOC100648995), (LOC100650427); cytochrome P450 9e2-like (LOC100647566), 
(LOC100648545), (LOC100649871), (LOC100649988)
bte-miR-375 1.22
bte-miR-252a 0.78 Dengue virus replication21 3′ UTR of SBPV
bte-miR-316 0.72
bte-miR-276 0.67 Olfactory41
putative odorant receptor 13a-like (LOC100647497); odorant receptor Or2-
like (LOC100644343); putative odorant receptor 82a-like (LOC100646456); 
odorant receptor 47b-like (LOC100646577); putative odorant receptor 13a-like 








Table 1.  Differentially expressed miRNAs upon virus infection.
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addition, a homolog of bte-miR-263b, which is upregulated by SBPV infection but not by the infection of IAPV, 
has been linked with apoptosis14.
Energy homeostasis (insulin-associated). A homolog of bte-miR-278, upregulated by IAPV infection, is involved 
in energy homeostasis resulting in the regulation of levels of insulin16 and regulation of the detoxification enzyme 
P450s17. Homologs of bte-miR-13a and -13b upregulated by IAPV and SBPV, respectively, regulate the expression 
of juvenile hormone (JH)18. JH plays an import role in regulation of insect growth and molting, which are also 
associated with ecdysone and insulin signaling pathways19. The homolog of another miRNA regulated by IAPV 
infection, bte-miR-305, was shown to regulate Notch and insulin pathways in the intestinal stem cells of the 
Drosophila melanogaster gut20.
Validation of reference miRNAs upon different time points of viral infections by RT-qPCR. 
Until now, there have not been stable reference miRNAs known to normalize the data upon viral infections and 
non-infection in bumblebees. With the pre-selection criteria, based on primers efficiency and specificity (Table S4 
and Figure S1), we eventually validated six miRNAs, including bte-miR-14, bte-miR-100, bte-miR-34, bte-miR-87, 
bte-miR-184 and bte-miR-281, in the same samples used to validate several key differentially expressed miRNAs 
indicated by small RNA sequencing. By geNorm, the results revealed that all these candidate reference miRNAs 
showed an M value of less than 1 except bte-miR-184, which showed an M value of 1.002 (Fig. 2A). Pairwise 
variations indicated the lowest V value of 0.165 (V4/5) upon the combination of the four most stable reference 
miRNAs (Fig. 2B). These results suggested the optimal references within these candidate reference miRNAs were 
the combination of four miRNAs, bte-miR-281 + bte-miR-34 + bte-miR-87 + bte-miR-100, for data analysis of 
miRNA expressions upon different injection time points of the two viruses.
To test the optimal reference miRNAs, we further evaluated the abundance of bte-miR-13b and bte-mc-24, the 
most potential miRNAs indicated by sequencing data to be involved in virus-host interaction, upon different time 
points after injection of the two viruses by RT-qPCR. The relative expressions of the miRNAs were normalized 
by four miRNAs selected above (miR-281 + bte-miR-34 + bte-miR-87 + bte-miR-100). At each time point, we 
separated PBS controls for two viruses, thus we used independent t-test to separate means but with Bonferroni 
correction as four comparisons for each virus were conducted, i.e. at four time points between virus injections 
and PBS injections. Therefore, the strict p value of 0.0125 was used to judge the statistical difference of miRNAs 
expressions. The fold change (log2 transformed) of miRNAs was calculated as the division of miRNAs expression 
in virus-injected samples by the very time points of PBS injected samples. The results showed that bte-miR-13b 
was upregulated at 48 and 72 h post-injection of SBPV, but only with significant difference at 72 h (p = 0.010) 
(Fig. 2C). The significant downregulation of bte-mc-24 (p < 0.001) was detected at 48 h post-injection of SBPV 
(Fig. 2D). These results were consistent with sequencing data and thereby these evaluated reference miRNAs 
could be used for further miRNA analysis upon virus infections.
In silico target prediction of differentially expressed miRNAs shows a possible host-virus inter-
action network mediated by miRNAs. The current understanding is that one miRNA may target hun-
dreds of genes, while a gene may be regulated by multiple miRNAs. Based on RNA22, we identified a total of 
7465 genes possibly targeted by 130 miRNAs in B. terrestris. Among them, 7216 genes were possibly targeted by 
23 differentially expressed miRNAs upon virus infection. Some predicted targets of these 23 miRNAs could be 
visualized in the GO and KEGG enrichments by ClueGO in two groups: 17 miRNAs differentially expressed by 
SBPV infection, and 12 miRNAs differentially expressed by IAPV infection. The analysis showed that there were 
32 and 21 groups of GO/KEGG pathways in the network of SBPV (Figure S2) and IAPV (Figure S3). A number of 
11 GO/KEGG pathways were common in the two datasets, which is consistent with the 6 common miRNAs influ-
enced by SBPV and IAPV infections. Generally, these pathways can be associated with certain level of molecular 
activities in the view of virus-host interaction, such as DNA/RNA, protein, metabolism, cell activity, host disease, 
and host antiviral immunity (Table 2). These visualizations of miRNA-mRNA-GO/KEGG enrichments may show 
a possible host-virus interaction network regulated by virus-influenced miRNAs. Moreover, these potential tar-
gets reported in the homologous miRNAs, some of them also show an overlap with our predictions (Table 1). A 
future direction of research could be the role of apoptosis and insulin associated energy homeostasis in host-virus 
interaction based on miRNAs.
In addition, we also explored if host miRNAs could directly target viral genomic RNAs using RNAhybrid and 
RNA22. The results identified a total of 24 target sites on SBPV and IAPV genomes by host miRNAs (Table 3). The 
predicted target sites were located in the UTRs as well as ORFs (open reading frame). Of these 24 target sites, 16 
were predicted to be targeted by differentially expressed miRNAs upon virus infections. We then applied a Chi 
square test to analyze whether these predictions, mainly linked with differential miRNAs, acted just by chance. 
We found a significant difference between the number of differentially expressed bumblebee miRNAs by each 
virus in targeting its own viral genomic RNAs and all bumblebee miRNAs in targeting viral genomic RNAs for 
both SBPV (χ 2 = 14.816, p < 0.001) and IAPV (χ 2 = 13.422, p < 0.001) analyses. This could suggest that the direct 
host miRNA-virus interplay might also play a role in bumblebee-SBPV/IAPV interaction. Intriguingly, a homolog 
of bte-miR-252a downregulated by SBPV, was shown to have a direct interaction with dengue virus (DENV) via 
targeting the DENV E protein transmembrane region21. Through RNAhybrid and RNA22, we also predicted that 
bte-miR-252a could possibly target the 3′ UTR of SBPV (Table 3).
Further analyses are needed to elucidate these direct miRNAs-virus interaction, which may provide us with 
an alternative strategy to use miRNAs to control the viruses or in a combination with the strategy of virus specific 
small interfering RNA (siRNA) and dsRNA through the siRNA pathway1.
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Depletion of dicer-1 by RNAi does not lead to an altered genome copy number of 
SBPV. Although our results showed an altered expression of dicer-1 and ago-1 and differential abundance 
of miRNAs upon virus infections, the role of the miRNA pathway itself on the outcome of viral pathogenicity 
is not clear. Therefore, we used RNAi to silence dicer-1 to detect its influence on the outcome of SBPV genome 
copy number (gcn), which was the avirulent infection and significantly influenced the expression of dicer-1, ago-
1 and miRNAs. Our result showed a ~77% depletion of dicer-1 transcripts after two days of injection of dsRNA 
(Fig. 3A). However, silencing of dicer-1 did not result in a significant difference in SBPV gcn (Fig. 3B). In our pre-
vious study, we also found that silencing of dicer-2 had no effect on IAPV and SBPV viral gcn, although silencing 
efficiency in dicer-2 depleted insects was reduced2. However, the answer to whether these results are associated 
with incomplete silencing of these key components from the RNAi pathway demands further study. In addition, 
it has been noted that various bumblebee tissues show different susceptibilities to viral infection22, but yet the 
virus-bumblebee interactions at the level of tissues rather than whole body or body parts awaits further studies. 
Recent studies showed that RNAi and JAK-STAT showed a cross-talk activity during viral infections23,24. In our 
previous study, we also detected the association between the RNAi and JAK/STAT pathways upon the infection 
of bee viruses in bumblebee25. Therefore, silencing of genes of the RNAi pathway could influence different (espe-
cially immune) pathways.
In conclusion, we found that an avirulent virus infection induced by SBPV and a virulent infection induced 
by IAPV in bumblebee B. terrestris could alter the miRNA pathway core genes’ expression and the abundance 
of miRNAs. It seems that based on the level of induction of dicer-1 and ago-1 and the number of differentially 
expressed miRNAs, the miRNA regulation was more disturbed or influenced after SBPV infection compared 
with IAPV infection. The potential target predictions and GO and KEGG enrichments were produced for ini-
tial visualization purposes and still lack any biological evidence, while it reflected the potential of bumblebee 
miRNAs that could be involved in various aspects of molecular activities in the view of virus-host interaction. 
In addition, some differentially expressed miRNAs upon virus infection may directly target the viral genome 
Figure 2. Validation of reference miRNAs upon different time points of IAPV and SBPV infections by RT-
qPCR. (A) M value of the candidate reference miRNAs analyzed in samples of different time points of IAPV and 
SBPV infections by geNorm. (B) Pairwise variations (V value) for the combination of the candidate reference 
miRNAs by geNorm. (C,D) The fold changes of bte-miR-13b and bte-miR-24 expressions were calculated by the 
ratio of the relative expression of miRNA in virus infected samples over the relative expression of this miRNA 
in control samples (PBS injected bees) (n = 3). The relative expression of miRNA was calculated based on the 
combination of four optimal reference miRNAs: bte-miR-281 + bte-miR-34 + bte-miR-87 + bte-miR-100. The 
error bar represents the standard error of mean. The level of significance was calculated by t-test and p < 0.0125 
was labeled with asterisks (*).
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based on our prediction. Further, the selected reference miRNAs could be used for miRNA expression analysis 
through RT-qPCR. In summary, our study opens a new insight into bee-virus interactions meditated by the 
miRNA pathway. These initial data and observations could direct and facilitate our further studies to search a host 
miRNA-based strategy to tackle bee viruses.
Methods
Insects and virus inoculation. The colonies of B. terrestris were obtained from Biobest NV (Westerlo, 
Belgium). The bees used in this study were screened by RT-PCR (Table S5) to make sure that they were free of 
SBPV and IAPV. Newly emerged workers within 24 hours were genuinely collected from various colonies (within 
Diff. exp. miRNAs upon SBPV infection Diff. exp. miRNAs upon IAPV infection
GO/KEGG ID name GO/KEGG ID name
KEGG:00250 Alanine, aspartate and glutamate metabolism KEGG:00250 Alanine, aspartate and glutamate metabolism
GO:0005524 ATP binding GO:0005524 ATP binding
KEGG:04360 Axon guidance KEGG:04360 Axon guidance
GO:0005975 carbohydrate metabolic process GO:0005975 carbohydrate metabolic process
GO:0003924 GTPase activity GO:0003924 GTPase activity
KEGG:05410 Hypertrophic cardiomyopathy (HCM) KEGG:05410 Hypertrophic cardiomyopathy (HCM)
GO:0048519 negative regulation of biological process GO:0048519 negative regulation of biological process
GO:0000166 nucleotide binding GO:0000166 nucleotide binding
GO:0006082 organic acid metabolic process GO:0006082 organic acid metabolic process
KEGG:03008 Ribosome biogenesis in eukaryotes KEGG:03008 Ribosome biogenesis in eukaryotes
KEGG:05202 Transcriptional misregulation in cancer KEGG:05202 Transcriptional misregulation in cancer
GO:0016887 ATPase activity GO:0006520 cellular amino acid metabolic process
GO:0016830 carbon-carbon lyase activity GO:0005856 cytoskeleton
KEGG:04110 Cell cycle GO:0003677 DNA binding
KEGG:04713 Circadian entrainment GO:0006259 DNA metabolic process
GO:0006732 coenzyme metabolic process GO:0004386 helicase activity
GO:0005794 Golgi apparatus GO:0008237 metallopeptidase activity
KEGG:04390 Hippo signaling pathway KEGG:04145 Phagosome
GO:0016788 hydrolase activity, acting on ester bonds GO:0004672 protein kinase activity
KEGG:04630 Jak-STAT signaling pathway GO:0038023 signaling receptor activity
GO:0000278 mitotic cell cycle KEGG:04530 Tight junction





KEGG:04015 Rap1 signaling pathway
GO:0010646 regulation of cell communication
GO:0010033 response to organic substance
KEGG:04550 Signaling pathways regulating pluripotency of stem cells
GO:0004888 transmembrane signaling receptor activity
KEGG:05203 Viral carcinogenesis
Table 2.  The most significant enriched GO/KEGG from the targets of differentially expressed miRNAs 
upon virus infection. Notes: pathways with bold are the same GO/KEGG appeared in both SBPV and 
IAPV dataset. These GO/KEGG could be associated with certain biological functions in the view of host-
virus interaction. Network of SBPV influenced miRNAs-targets-GO/KEGG: In DNA/RNA associated GO/
KEGG, (GO:0005524), (GO:0003924), (GO:0000166), (GO:0016887), (GO:0001882), (KEGG:00230). In 
protein associated GO/KEGG, (KEGG:00250), (KEGG:03008), (GO:0005794), (GO:0006508). In metabolism 
associated GO/KEGG, (GO:0005975), (GO:0006082), (GO:0016830), (GO:0006732). In cell activity 
associated GO/KEGG, (KEGG:04110), (GO:0000278), (KEGG:04015), (GO:0010646), (GO:0010033), 
(KEGG:04550), (GO:0004888). In host disease associated GO/KEGG, (KEGG:05410), (KEGG:05202), 
(KEGG:05203). In host antiviral immunity associated GO/KEGG, (KEGG:04390), (KEGG:04630). Network 
of IAPV influenced miRNAs-targets-GO/KEGG: In DNA/RNA associated GO/KEGG, (GO:0005524), 
(GO:0003924), (GO:0000166), (GO:0003677), (GO:0006259), (GO:0004386). In protein associated GO/KEGG, 
(KEGG:00250), (KEGG:03008), (GO:0006520), (GO:0008237), (GO:0004672). In metabolism associated GO/
KEGG, (GO:0005975), (GO:0006082). In cell activity associated GO/KEGG, (GO:0005856), (GO:0038023), 
(KEGG:04530). In host disease associated GO/KEGG, (KEGG:05410), (KEGG:05202). In host antiviral 
immunity Phagosome (KEGG:04145).
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each experiment a maximum of 2 newly emerged workers were collected from a single colony, this was to ensure 
a random genetic background and to avoid overlap between treatment and genetic background) to keep the 
homogeneity of bees used in this study and kept in micro-colonies fed with pollen and sugar water ad libitum 
for further experiments. All the micro-colonies were maintained in an incubator (Panasonic, Japan) at 29–31 °C, 
60–65% relative humidity, and continuous darkness26.
Virus inocula were produced as described previously26. The virus particles were counted by using transmis-
sion electron microscopy. To inoculate bees, we injected 20,000 and 20 particles of SBPV and IAPV into five to 
eight days old workers on the side of the soft white-like cuticle between the 1st and 2nd abdominal segments by a 
nanoinjector (Eppendorf, Germany) according to a previous study2. PBS (10 mM phosphate buffer pH 7.0/0.02% 
diethyl dithiocarbamate) injected bumblebees served as control, which was the same solution used to purify viral 
samples. Although both viruses replicate very fast, we define SBPV as an avirulent virus infection while IAPV 
represent a highly virulent infection as the injection of SBPV causes no mortality and IAPV causes extremely high 
mortality after 3 days and 100% mortality around 8 days2.
RNA isolation, cDNA synthesis, and qPCR. A total of 1.5~2 ml RLT buffer was initially used to homog-
enize the individual bumblebee by mortar and the supernatant was centrifuged three times to remove debris. 
Thereafter, the protocol of the RNeasy mini kit (Qiagen, Germany) was followed. The TURBO DNA-free™ kit 
(Ambion, USA) was used to remove the possible genomic DNA contamination in RNA samples. The quantity and 
quality of RNA samples were checked by Nanodrop and electrophoresis on 1.5% agarose gel. An amount of 2 μ 
g total RNA was used to synthesize the cDNA by SuperScript® II Reverse Transcriptase (Invitrogen, USA) using 
oligo (dT) primers. To make sure there was no genomic DNA contamination, we checked cDNA samples by PCR 
with exon spanning primers for RPL23 (Table S5). The cDNA should produce an amplicon of 143 bp whereas the 
presence of genomic DNA will produce an extra amplicon of 452 bp. Next, qPCR was performed on a CFX96™ 
Real-Time PCR Detection with GoTaq® qPCR master (Promega, USA). Each reaction was performed in dupli-
cate. The amplification specificities of primers used in this study were checked by both electrophoresis of the 
RT-PCR products and analysis of the dissociation curve by qPCR. A 10-fold serial dilution of cDNA was applied 
to calculate the amplification efficiency (Table S5). In addition, the RT-PCR products were sequenced in order to 
confirm their primers’ amplification specificities.
Core gene expression of the miRNA pathway. We collected RNA samples at 8 h, and 1, 2, 3, 7 and 
13 dpi with SBPV and 8 h, and 1, 2, and 3 dpi with IAPV, to analyze gene expressions (n = 4~5). These time 
points were ascertained from previous study in consideration of the viral replication and viral caused mortality2. 
For each bumblebee individual, the whole body of each individual bee was used to extract RNA. PBS injected 
bees were also collected at all the different time points to serve as non-infected controls. Four to five bumblebee 
Target miRNA MFE (Kcal/mol) Binding Site Start Position Target Gene Annotation
SBPV bte-miR-276 − 21.8 7261 Polyprotein_ORF
SBPV bte-miR-276 − 20.7 2285 Polyprotein_ORF
IAPV bte-bantam − 25 4919 Polymerase Polyprotein_ORF
IAPV bte-mc-24 − 28.5 6219 Polymerase Polyprotein_ORF
IAPV bte-mc-24 − 28.1 6554 UTR
IAPV bte-mc-24 − 25 328 5′ UTR
SBPV bte-miR-252a − 29.6 9370 3′ UTR
SBPV bte-miR-9a − 25.1 3777 Polyprotein_ORF
IAPV bte-miR-11 − 21.8 7752 Structural Polyprotein_ORF
IAPV bte-miR-283 − 20.8 1145 Polymerase Polyprotein_ORF
IAPV bte-mc-24 − 22.5 9474 3′ UTR
IAPV bte-mc-753 − 22.4 7878 Structural Polyprotein_ORF
SBPV bte-miR-263b − 21.9 3705 Polyprotein_ORF
SBPV bte-miR-276 − 22.9 2500 Polyprotein_ORF
SBPV bte-miR-3759 − 23.3 7714 Polyprotein_ORF
SBPV bte-mc-24 − 20.1 9239 3′ UTR
SBPV bte-mc-753* − 26.3 7748 Polyprotein_ORF
IAPV bte-miR-263b* − 24.2 8501 Structural Polyprotein_ORF
IAPV bte-miR-9a* − 20.2 5318 Polymerase Polyprotein_ORF
IAPV bte-miR-252a* − 22.2 3819 Polymerase Polyprotein_ORF
IAPV bte-miR-252a* − 21.8 7091 Structural Polyprotein_ORF
IAPV bte-miR-263b* − 20.1 6255 Polymerase Polyprotein_ORF
IAPV bte-miR-750* − 21.9 1993 Polymerase Polyprotein_ORF
SBPV bte-miR-305* − 22.7 785 Polyprotein_ORF
Table 3.  Predicted targets of host miRNAs in the viral genomes. *Not differentially expressed due to that 
particular viral infection.
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individuals were included in each time point for virus and PBS. The relative expression of key components, dicer-
1 and ago-1, of the miRNA pathway were normalized by internal control peptidylprolyl isomerase A (PPIA)26. 
The fold change of gene expression at each time point was given as the ratio of the relative gene expressions of the 
virus treated samples over the PBS controls collected at the same time point.
Small RNA sequencing and target prediction of miRNAs. Small RNA sequencing was performed 
on RNA samples of SBPV and IAPV at 2 dpi, representing a fast replicating stage of IAPV and SBPV2. The PBS 
injected bees were included as control. For each bumblebee individual, the whole body of each individual bee 
was used to extract RNA. Four bumblebee individuals for each treatment and control were sequenced by the 
NXTGNT sequencing platform from the Ghent University. In detail, concentration and quality of the total 
extracted RNA was checked using the Quant-iTTM RiboGreen® RNA assay kit (Invitrogen, USA) and the RNA 
6000 pico chip (Agilent Technologies, USA). Subsequently, 1 μ g of total RNA was used to start the library prepara-
tion using the TailorMix miRNA Sample Preparation Kit v7 (SeqMatic, USA). Library preparation was carried out 
according to the manufacturer’s instructions. Then tRNA was added as carrier to minimize the loss of RNA via 
tube interaction. Libraries were quantified by qPCR, according to Illumina’s protocol ‘Sequencing Library qPCR 
Quantification protocol guide’ (version February 2011). A high sensitivity DNA chip (Agilent Technologies, USA) 
was used to check the libraries’ size distribution and quality. Single-end index 50 bp sequencing was performed on 
an Illumina MiSeq sequencer by loading 7 pM of each sample on the flowcell. A 10% PhiX spike-in was added as 
control. An average sequencing depth of 1.2 million reads in each sample was performed.
Ambiguous and low quality bases and adaptor sequences were trimmed from the sequencing reads using CLC 
Genomics Workbench 7.0.2. No ambiguous bases were allowed and a quality setting of 0.05 was applied. Reads 
smaller than 15 bp after trimming or reads containing more than 10% of bases with Phred quality score lower than 
20 were filtered with CLC Genomics Workbench 7.0.2 and fastX-toolkit 0.0.13.1, respectively. The miRNA reads 
were counted by CLC Genomics Workbench 7.0.2 based on annotated bumblebee miRNA dataset12. Differential 
expression analysis between virus-infected and non-infected bees was performed in the R Bioconductor-package 
limma on quantile normalized data. The results were corrected by multiple testing using a Benjamini-Hochberg 
False Discovery Ratio at a cut-off value of 0.05. To select differentially expressed miRNAs, we used a strict criteria 
based on miRNA counts (greater than 100), fold change (larger than 20% difference), and adjusted p value (less 
than 0.01).
In this study, we screened the B. terrestris annotated mRNAs to identify potential miRNA binding sites using 
the core algorithm of improved version RNA22 v227. This tool is publicly available from Computational Medicine 
Centre of Thomas Jefferson University (https://cm.jefferson.edu/rna22). RNA22 is a pattern based target predic-
tion program which first searches for reverse complementary sites of patterns within given mRNA sequences and 
identifies the hot spots. In the next step, the algorithm searches for miRNAs that are likely to bind to these sites. 
We allowed maximum one mismatch in the seed region and minimum 12 nt matches in the entire binding site. 
We set the sensitivity and specificity thresholds at 63% and 61%, respectively.
To further view the potential targets of miRNAs with differential expressions upon viral infections, we built 
a network of enrichment of Gene Ontology (GO) terms or Kyoto Encyclopedia of Genes and Genomes (KEGG) 
pathways by ClueGO28. Briefly, ClueGO is a Cytoscape plug-in App to facilitate the visualization of functionally 
grouped terms in the form of networks and charts. We used a maximum of 25 predicted targets per miRNAs 
(folding energy cut-off: − 20 Kcal/mol) as input. The GO term retrieved from Uniprot (ftp://ftp.ebi.ac.uk/pub/
databases/GO/goa/UNIPROT/) and KEGG annotation (http://www.genome.jp/kegg/kegg2.html) of B. terrestris 
Figure 3. Silencing of dicer-1 and its effect on the genome copy number of SBPV. (A) The injection of 
dsDicer-1 (n = 5) to target dicer-1 led to 77.2% reduction of its transcript levels compared with injection of the 
negative control dsGFP (n = 5). (B) Pre-silencing of dicer-1 led to no difference of genome copy number of 
SBPV (n = 12).
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were input with ClueGO main id, Entrez gene ID. The default parameters of ClueGO 2.1.7 were used for network 
construction. In details, the GO term level was defined with minimum 3 and maximum 8; in each term cluster, 
it required a minimum of 3 genes with a minimum of 4.0% clustered genes over the total genes in the term. The 
enrichment of predicted target genes of miRNAs to GO term/KEGG pathway was tested based on the hyperge-
ometric distribution. A further multiple testing was followed by Bonferroni step-down. Finally, ClueGO created 
a binary gene-term matrix with the selected terms and their associated genes. Based on this matrix, a term-term 
similarity matrix was calculated using chance corrected kappa statistics to determine the association strength 
between the terms. In the current analysis, we used a cut-off value 4.0 for kappa score, to represent the most sig-
nificant (leading) terms in associated functional groups, which could be visualized in the network.
In addition, we also predicted the potential targets of B. terrestris miRNAs in SBPV and IAPV genomic RNA 
by RNA2227 and RNAhybrid29, which use different prediction assumptions and thus made our prediction more 
reliable. RNAhybrid is a tool for finding the normalized minimum free energy of hybridization for miRNA and 
their mRNA target genes. The small RNA sequence is hybridized to the best fitting part of the mRNA. We did not 
allow G:U pairing in the seed region (nucleotide 2–8) and forced miRNA-target duplexes to have a helix in this 
region. Maximum 5 nt were approved as unpaired nucleotides in either side of an internal loop. The outcomes of 
the two tools were merged, and miRNA binding sites that were predicted by both tools were considered highly 
confident.
Validation and expression analysis of miRNAs by RT-qPCR. The same samples collected at 8, 24, 
48, 72 h (n = 3) for both virus injections and PBS controls were used to further analyze the expressions of miR-
NAs. An amount of 2 μ g total RNA was used to prepare cDNA by miScript® II RT kit (QIAGEN, Germany). To 
quantify mature miRNAs in the study, the 5x miScript HiSpec buffer was used. The total volume of 20 μ l reaction 
system was mixed by adding buffer, nucleic acids mix, reverse transcriptase mix, RNA template and RNase-free 
water, and then followed the protocol of the kit. For RT-qPCR, an volume of 20 μ l reaction system was mixed by 
adding SYBR green PCR master mix, universal primer (provided by the kit), miRNA specific primer (Table S4), 
template cDNA prepared above and RNase free water, by following the protocol of miScript SYBR® Green PCR 
kit (QIAGEN, Germany). Each reaction contained two technical replicates. To check the efficiency and specificity 
of miRNA primers, we evaluated the miRNAs’ amplification efficiencies by using a 10-fold serial dilution of mix-
ture cDNA and the melting curves in all tested cDNA samples.
The validation of references as the same principle of mRNA expressions through RT-qPCR, was also suggested 
before the detection of miRNAs’ expressions30,31. To select good candidate reference miRNAs, we selected those 
with high counts (>100) and low expression variabilities indicated by sequencing data. Some miRNAs with sig-
nificant changes upon viral infections revealed by the small RNA sequencing (section 2.4) were chosen to analyze 
their expressions in samples described above. The analysis of stable reference miRNAs was calculated by plug-in 
software geNorm in qBasePLUS and the relative expressions of miRNAs were normalized by selected optimal ref-
erence miRNAs through qBasePLUS.
Silencing Dicer-1 and detection of its effect on viral genome copy number. The same protocol 
of RNAi to silence a specific gene was performed according to our previous study2. A fragment of dicer-1 was 
amplified by PCR with target gene sequence specific primers plus T7 promoters (Table S5). This partial DNA 
template was purified by E.Z.N.A.® Cycle-Pure Kit (Omega, USA), and was sequenced in order to confirm the 
identity of the amplification. Then, 1 μ g of template was used to synthesize dsRNA according to the guideline of 
MEGAscript® RNAi Kit (Invitrogen, USA). The concentration and quality of dsRNA were verified by Nanodrop 
and electrophoresis on 1.5% agarose gel. A total of 20 μ g (20 μ l) of dsRNA was injected into five to eight days old 
workers, and the same dose of dsGFP served as negative control. We used RNAi approach to investigate whether 
silencing of dicer-1 influences the genome copy number (gcn) of SBPV. First we silenced dicer-1 by injection of 
dsDicer1 (dsGFP serves as a control). After two days, the second injections were performed to inoculate bees 
with SBPV. Subsequently, in each sample, the abdomen of individual bumblebees was used for RNA extractions. 
To only measure the dicer-1 silencing efficiency, five bumblebee individuals were used. For detecting the genome 
copy number of SBPV upon silencing of dicer-1, 12 bumblebee individuals were included. The whole experiment 
was repeated twice.
The measurement of SBPV gcn was based on a standard curve made from the Cq values (x) detected from a 
dilution of DNA templates of partial SBPV genome converting to corresponding gcn (y)2. In detail, a part of the 
SBPV genome (Table S5) was amplified and purified by E.Z.N.A.® Cycle-Pure Kit (Omega, USA). The partial 
sequence was confirmed by Sanger sequencing (LGC genomics, Germany). The concentration of purified tem-
plates was measured by Quant-iTTM PicoGreen® dsDNA assay kit (Invitrogen, USA). The concentration was con-
verted to gcn per μ l by the online tool (URL: http://cels.uri.edu/gsc/cndna.html; Accessed date: 20/June/2014). A 
10 fold serial dilution of templates was made to obtain a standard curve for each virus by qPCR. The equation is 
y = -0.2926x + 9.4426 (R2 = 0.9996). The normalized gcn of each sample was represented by the ratio of the gcn 
calculated based on the standard curve and the normalization factor from the internal reference gene PPIA26 with 
the framework of qBase32.
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